Epstein—Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed

Epstein—Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed—Sternberg cells

Published:2000-01 Issue:1 Volume:11 Page:91-96
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Naresh K.N.,Johnson J.,Srinivas V.,Soman C.S.,Saikia T.,Advani S.H.,Badwe R.A.,Dinshaw K.A.,Muckaden M.,Magrath I.,Bhatia K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/1/91/19478027/11-1-91.pdf

Reference36 articles.

1. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV;Nilsson;Int J Cancer,1971

2. Epstein–Barr virus in tumours;Anagnostopoulos;Histopathology,1996

3. Normal and malignant B-cell development with special reference to Hodgkin’s disease;Rajewsky;Ann Oncol,1997

4. The expression of the B-cell marker mb-l (CD79a) in Hodgkin’s disease;Korkolopoulou;Histopathology,1994

5. A Epstein–Barr virus-associated Hodgkin’s disease: Epidemiologic characteristics in international data;Glaser;Int J Cancer,1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein-Barr virus-based prognostic model in nodular sclerosis classic Hodgkin lymphoma;iScience;2024-01

2. The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis;Frontiers in Oncology;2022-10-27

3. Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL;Cancers;2022-09-01

4. Hodgkin Lymphoma in Children Under 5 Years: Do They Behave Differently?;Journal of Pediatric Hematology/Oncology;2022-03-16

5. Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma;Human Pathology;2022-01